283 related articles for article (PubMed ID: 22090023)
1. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines.
Hui-Yuen J; McAllister S; Koganti S; Hill E; Bhaduri-McIntosh S
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22090023
[TBL] [Abstract][Full Text] [Related]
2. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
Nagy N
Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
[TBL] [Abstract][Full Text] [Related]
3. Effect of Interleukins on Antibody Production by Epstein-Barr Virus Transformed B Cells.
Ali AI; Badran YR; Hassuneh MR; Sanber KS; Ismail SI
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):162-8. PubMed ID: 26090593
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
[TBL] [Abstract][Full Text] [Related]
5. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
6. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A.
Pelloquin F; Lamelin JP; Lenoir GM
In Vitro Cell Dev Biol; 1986 Dec; 22(12):689-94. PubMed ID: 3023278
[TBL] [Abstract][Full Text] [Related]
7. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA
J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490
[TBL] [Abstract][Full Text] [Related]
9. Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
Levhar N; Ungar B; Kopylov U; Fudim E; Yavzori M; Picard O; Amariglio N; Chowers Y; Shemer-Avni Y; Mao R; Chen MH; Ye Z; Eliakim R; Ben-Horin S
Inflamm Bowel Dis; 2020 Aug; 26(9):1330-1339. PubMed ID: 32322878
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
Nikiforow S; Bottomly K; Miller G
J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
[TBL] [Abstract][Full Text] [Related]
11. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
Wilson AD; Morgan AJ
J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
[TBL] [Abstract][Full Text] [Related]
12. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
Wilson AD; Redchenko I; Williams NA; Morgan AJ
Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
[TBL] [Abstract][Full Text] [Related]
14. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E
Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932
[TBL] [Abstract][Full Text] [Related]
16. Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines.
Jeon JP; Nam HY; Shim SM; Han BG
Mol Cells; 2009 Feb; 27(2):143-8. PubMed ID: 19277495
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
Chen X; Kamranvar SA; Masucci MG
Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
[TBL] [Abstract][Full Text] [Related]
18. WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Okubo M; Kobayashi T; Goto M; Ide T; Furuichi Y
Cancer Genet Cytogenet; 2004 Jul; 152(2):95-100. PubMed ID: 15262425
[TBL] [Abstract][Full Text] [Related]
19. [Human B-lymphoblastoid cell lines: optimal conditions for their procurement, selection, cultivation and cloning].
Deriugina EI; Olovnikova NI; Lemeneva LN; Drize NI; Belkina EV; Chertkov IL
Gematol Transfuziol; 1991 Aug; 36(8):3-7. PubMed ID: 1661250
[TBL] [Abstract][Full Text] [Related]
20. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
